Table 3.
Variables | Increase in migraine frequency | Increase in migraine severity | ||
---|---|---|---|---|
AOR (95%CI) | p-value | AOR (95%CI) | p-value | |
Gender (female) | 0.769 (0.491–1.203) | 0.250 | 0.643 (0.419–0.986) | 0.043* |
Disease onset | 0.984 (0.965–1.003) | 0.089 | 0.978 (0.960–0.996) | 0.018* |
Difficulty in getting medications | 1.012 (0.715–1.810) | 0.040* | 1.271 (0.872–1.853) | 0.002* |
Non-compliance to treatment | 0.579 (0.418–0.804) | 0.001* | 1.655 (1.204–2.274) | 0.002* |
Medication overuse | 11.603 (8.403–16.023) | < 0.001* | 8.179 (5.963–11.218) | < 0.001* |
Sleep disturbance | 2.113 (1.375–3.248) | 0.001* | 1.562 (1.041–2.344) | 0.031* |
Eating habits disturbance | 1.702 (1.178–2.459) | 0.005* | 1.778 (1.247–2.536) | 0.001* |
Symptoms of anxiety and/or depression | 1.257 (0.823–1.918) | 0.290 | 1.558 (1.043–2.329) | 0.030* |
Use of traditional medicine | 1.465 (1.049–2.045) | 0.071 | 1.361 (0.984–1.882) | 0.063 |
Working during pandemic | 1.356 (1.169–2.368) | 0.005* | 1.241 (0.906–1.699) | 0.001* |
Lack of communication with treating physician | 1.983 (0.898–2.730) | 0.001* | 1.776 (0.898–2.938) | 0.001* |
Lack of regular exercise | 1.257 (0.898–1.761) | 0.183 | 1.223 (0.898–1.412) | 0.234 |
AOR: Adjusted odds ratio
CI: Confidence interval
*: Statistically significant at p ≤ 0.05